In the second quarter of 2011, Stryker reported $2.05 billion in net sales, a 12 percent increase over last year, according to a company news release.
The company can attribute its financial success to product line sales, including the sale of reconstructive products, MedSurg products and neurotechnology and spine products. There was a higher recorded shipment of hip, trauma and extremities implant systems, which offset lower shipments of knee and other implant systems. However, the company also experienced a 3.1 percent net earnings decrease from $319 million in the second quarter of 2010 to $309 million during the second quarter of 2011.
The company's hip business reported $312 million, an 11 percent increase over last year. The knee business only experienced a 4 percent increase to $328.5 million during the second quarter of this year. The company's spine business experienced an 8 percent increase to $169 million.
During the second quarter, Stryker also acquired Orthovita.
Read the release on the financial report from Stryker.
Related Articles on Stryker:
Stryker Partners With RegenLab for Distributing PRP Kit
Stryker Releases ADM X3 Mobile Bearing Hip System
Staying Competitive in the Orthopedic Device Market: Q&A With Stryker Orthopaedics
The company's hip business reported $312 million, an 11 percent increase over last year. The knee business only experienced a 4 percent increase to $328.5 million during the second quarter of this year. The company's spine business experienced an 8 percent increase to $169 million.
During the second quarter, Stryker also acquired Orthovita.
Read the release on the financial report from Stryker.
Related Articles on Stryker:
Stryker Partners With RegenLab for Distributing PRP Kit
Stryker Releases ADM X3 Mobile Bearing Hip System
Staying Competitive in the Orthopedic Device Market: Q&A With Stryker Orthopaedics